Summit Trail Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$216K	Buy	+1,719	New	+$216K	﹤0.01%	1033
2018 Q1	–	Sell	-155	Closed	-$14K	–	1224
2017 Q4	$14K	Buy	+155	New	+$14K	﹤0.01%	1133